Tissue Engineered Veins in Patients With Chronic Venous Insufficiency

Summary

This study aims to evaluate the safety (incidence of adverse events including serious adverse events and clinical significant laboratory abnormalities) of personalized tissue engineered veins (P-TEV) with valves implanted in patients with severe chronic venous insufficiency (CVI). For each patient a segment of the femoral vein containing the non-functioning valve will be surgically replaced with a single P-TEV containing a functioning valve.

Timeline

Start

2021-12-15

Primary completion

2025-06

Completion

2025-06

Drugs

Indications